What's New

Wave Life Sciences Ends FTD/ALS Trial of WVE-004

Yesterday, Wave Life Sciences announced that it ended its FOCUS-C9 clinical trial for the drug WVE-004, which was being evaluated as a potential treatment for FTD and amyotrophic lateral sclerosis…

Read More about Wave Life Sciences Ends FTD/ALS Trial of WVE-004

Advancing Hope: Major Leaders in FTD and ALS Research Gather in Arizona for Summit on C9orf72 Gene

In March, prominent leaders in FTD and ALS research gathered in Scottsdale, Arizona, for the first-ever summit on the C9orf72 gene, variations of which constitute the most common cause of…

Read More about Advancing Hope: Major Leaders in FTD and ALS Research Gather in Arizona for Summit on C9orf72 Gene

FTD Can Produce a Creative Spark in Some, Study Finds

Brain atrophy patterns specific to FTD can let loose previously suppressed creative abilities in some people diagnosed with the disease, according to a study published earlier this year in JAMA…

Read More about FTD Can Produce a Creative Spark in Some, Study Finds

“What Do People with PPA Want from Speech-Language Therapy?” Recent Study Asks

A study published in the International Journal of Language and Communication Disorders explores the needs of people affected by primary progressive aphasia (PPA) and how speech-language therapy (SLT) can be…

Read More about “What Do People with PPA Want from Speech-Language Therapy?” Recent Study Asks

May’s Athlete of the Month: Dane Sundseth

AFTD’s May Charity Miles Athlete of the Month is Dane Sundseth from Southern California! After a friend of his family member was diagnosed with FTD, Dane made a choice to…

Read More about May’s Athlete of the Month: Dane Sundseth

May 25: 2023 Woodland Senior Resource Fair

AFTD volunteer Debby Scanlan will be representing AFTD at the 2023 Woodland Senior Resource Fair in Woodland, California. She will be hosting an information table to bring awareness of FTD…

Read More about May 25: 2023 Woodland Senior Resource Fair

May 31: Aging Unbound Fair

AFTD will be hosting an information table at the Aging Unbound Fair on May 31 in Burke, Virginia, near Washington, DC. Additionally, AFTD volunteer Sarah Beil will speak about how…

Read More about May 31: Aging Unbound Fair

AFTD and ALS Association Launch Funding Opportunity for Digital Tool Development in ALS and Frontotemporal Dementia

AFTD and The ALS Association are launching a funding opportunity to support collaborative development of digital assessment tools across two overlapping neurodegenerative disorders: frontotemporal degeneration (FTD) and amyotrophic lateral sclerosis…

Read More about AFTD and ALS Association Launch Funding Opportunity for Digital Tool Development in ALS and Frontotemporal Dementia

June 1: In-Person Meet & Greet in Fredericksburg, VA

Join and learn from others who understand the FTD journey at this in-person AFTD Meet & Greet event in Fredericksburg, Virginia on June 1, starting at 5 p.m. Download this…

Read More about June 1: In-Person Meet & Greet in Fredericksburg, VA

Researchers Review Efficacy of Cognitive Exams in Recent Study

Researchers set out to evaluate the efficacy of three prominent cognitive exams used to screen people for FTD and other dementias in a recent study published in the medical journal…

Read More about Researchers Review Efficacy of Cognitive Exams in Recent Study